Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

J. James Jenkins, Jr.

Member

Nashville
(615) 742-6236 TEL
(615) 742-2736 FAX

J. James Jenkins, Jr.

Member

Nashville
(615) 742-6236 TEL
(615) 742-2736 FAX
Nashville
(615) 742-6236 TEL
(615) 742-2736 FAX

Jim Jenkins has assisted clients in hundreds of transactions involving corporate mergers and acquisitions, and the acquisition and disposition of hospitals, surgery centers, managed care plans and physician group practices. Over the last 10 years, Jim has led deals with a combined value of over $25 billion.

His practice encompasses mergers and acquisitions of both public and private acquirors and targets, public equity and debt offerings, private placements of securities, and strategic relationships, such as joint ventures and corporate partnerships. Jim also provides advice on operational matters and counsels clients on a variety of other corporate and securities matters, including corporate governance.

Jim Jenkins has assisted clients in hundreds of transactions involving corporate mergers and acquisitions, and the acquisition and disposition of hospitals, surgery centers, managed care plans and physician group practices. Over the last 10 years, Jim has led deals with a combined value of over $25 billion.

His practice encompasses mergers and acquisitions of both public and private acquirors and targets, public equity and debt offerings, private placements of securities, and strategic relationships, such as joint ventures and corporate partnerships. Jim also provides advice on operational matters and counsels clients on a variety of other corporate and securities matters, including corporate governance.

His practice includes:

  • Healthcare Mergers, Acquisitions & Dispositions – Counseling on a wide variety of business combinations and other related transactions whether acquisitions, business combinations, joint ventures, strategic investments, syndications, restructurings, workouts or dispositions.
  • Healthcare Finance – Coordinating financing transactions for issuers, underwriters and purchasers including public debt and equity, private placements of securities and private equity investments.
  • Corporate Governance – Advising boards, directors, officers and other executives on contracting, regulatory, disclosure and operational concerns.

Jim currently serves on the firm's Executive Committee. Previously, he served as Chair of the firm's Healthcare Practice (2011-2015) and as the firm's hiring partner. 

+ Read More

- Read Less

Memberships

American Health Lawyers Association (AHLA)

Nashville Health Care Council — Leadership Health Care

News

View More

Representative Experience

View More

Additional Experience

Representative transactions include the following:

Merger and Acquisition Transactions

  • Represented a NASDAQ-listed healthcare services company in its $10.5 billion strategic merger transaction
  • Represented NASDAQ-listed healthcare services company in its $2.3 billion acquisition of a privately-held physician services business
  • Represented a NYSE-listed managed care company in its $7.2 billion strategic merger transaction
  • Represented a NYSE-listed managed care company in its $3.8 billion strategic merger transaction
  • Represented a NASDAQ-listed physician services company in the acquisition of multiple physician practices with a combined transaction value of our $1.5 billion
  • Represented a NASDAQ-listed operator of outpatient surgical facilities in over 150 acquisitions and joint ventures
  • Represented a privately-held hospital company in the acquisition of three acute care hospitals
  • Represented a NASDAQ-listed operator of outpatient surgical facilities in its $135 million acquisition of a privately-held company.
  • Represented a NYSE-listed managed care company in its $545 million acquisition of a privately-held managed care plan
  • Represented a NYSE-listed managed care company in its $405 million acquisition of a privately-held managed care plan
  • Represented a privately-held managed care company in a $435 million recapitalization transaction
  • Represented a NYSE-listed senior living company in its approximately $200 million acquisition of a privately-held senior living company

Public Securities Transactions

  • Represented a NASDAQ-listed healthcare services company in its offerings of common stock, preferred stock and senior notes generating proceeds in excess of $2.5 billion
  • Represented a NYSE-listed managed care company in its initial public offering of 21,620,000 shares of common stock and its public offering of 11,600,000 shares of common stock
  • Represented an owner and operator of hospitals in its $100.0 million offering of senior subordinated notes
  • Represented a NYSE-listed senior living company in its exchange of outstanding convertible subordinated debentures for a combination of newly issued senior subordinated notes and convertible subordinated notes
  • Represented a NYSE-listed managed care company in its public offering of 8,050,000 shares of common stock and its offering of $175.0 million of senior notes
  • Represented a NYSE-listed senior living company in its initial public offering of 3,593,750 shares of common stock and its public offerings of $138.0 million of convertible subordinated debentures and 4,500,000 shares of common stock

Publications

View More

Upcoming Events

Past Events

View More

Media Mentions

View More

Accolades

Chambers USA — Healthcare (2014-2016)

Best Lawyers in America® — Banking and Finance Law; Corporate Governance Law; Corporate Law; Health Care Law; Mergers and Acquisitions Law; Securities / Capital Markets Law (2007-2017)

Best Lawyers in America® — Nashville Securities / Capital Markets Law "Lawyer of the Year" (2017)

Nashville Medical News InCharge Healthcare (2014-2016)

Mid-South Super Lawyers "Rising Star" (2009)

SMU Law Review Association — Research Editor (1992-1994)

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.